Schizophrenia is a mental health condition that disrupts several different areas of the brain. This condition typically affects thinking abilities, memories, and senses. Antipsychotic medications and maintenance-electroconvulsive therapy (m-ECT) are the cornerstone of schizophrenia treatment. This case report focuses on a 21-year-old woman with Schizophrenia on m-ECT and antipsychotic medication. Her symptoms did not subside with drug therapy and she was started with m-ECT. Five ECT sessions were given to her with antipsychotic medication. The patient’s mood, appearance, behaviour, perception and self-care improved after m-ECT. As a result of the collaboration between the clinical pharmacists and the multidisciplinary team in the management of the patient, her insight improved eventually. Literature collected from various countries (UK, Poland, Japan, Korea, USA and Malta) stated that schizophrenia can be successfully treated with m-ECT. We discuss the importance of recognizing and treating the patient with schizophrenia with antipsychotic medication and m-ECT. There is a need for further research on the correlation between schizophrenia on m-ECT and drug therapy in young adults.
No takes yet. Share an insight, caveat, or question.
Suganya et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: